Forte Biosciences, Inc. (FBRX) Dividend History

Forte Biosciences, Inc. (FBRX) is a biotechnology company focused on developing targeted therapies for inflammatory skin diseases, particularly atopic dermatitis. The company aims to leverage its proprietary microbiome and immune-modulating platform to create innovative treatments that address unmet medical needs in dermatology.

3060 Pegasus Park Drive, Dallas, TX, 75247
Phone: (310) 618-6994
Website:

Dividend History

Forte Biosciences, Inc. currently does not pay dividends

Company News

  • Forte Biosciences (FBRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

    Zacks Investment Research
  • The Dow Jones index closed higher by over 150 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform. OLB Group The Trade: The OLB Group, Inc. (NASDAQ: OLB) Chairman and CEO Ronny Yakov acquired a total of 22,315 shares an average price of $0.75. To acquire these shares, it cost around $16,739. What’s Happening: On Nov. 15, the company posted a wider-than-expected quarterly loss. What OLB Group Does: The OLB Group Inc is a diversified fintech ...

    Benzinga
    Featured Companies: OLB REFR SDOT
  • The Dow Jones closed higher by over 100 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform. Forte Biosciences The Trade: Forte Biosciences, Inc. (NASDAQ: FBRX) Director Paul A Wagner acquired a total of 51,203 shares an average price of $0.60. To acquire these shares, it cost around $30,468. What’s Happening: On Nov. 13, Forte Biosciences posted a wider third-quarter loss. What Forte Biosciences Does: Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its ...

    Benzinga
    Featured Companies: COMM ERAS
  • The Dow Jones closed higher by over 180 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform. Beasley Broadcast The Trade: Beasley Broadcast Group, Inc. (NASDAQ: BBGI) CEO Caroline Beasley acquired a total of 14,285 shares an average price of $0.73. To acquire these shares, it cost around $10,428. What’s Happening: Beasley Broadcast Group posted a loss for the third quarter. What Beasley Broadcast Does: Beasley Broadcast Group Inc is a multi-platform media company, whose primary ...

    Benzinga
    Featured Companies: BBGI CLRO
  • Penny stocks to watch this month. The post Penny Stocks To Buy Now? 4 To Watch In April appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

    PennyStocks
    Featured Companies: THCH
Dividend data last updated 06/08/2025 00:06:33 UTC